[Effect of tazanolast on platelet activating factor-induced airway hyperresponsiveness in guinea pigs]. 1992

T Hashimoto, and Y Toyoda, and H Matsukawa, and Y Tsuriya, and Y Yanagihara
Research Institute, Wakamoto Pharmaceutical Co., Ltd.

To determine whether tazanolast inhibits airway hyperresponsiveness, we studied the effect of this drug on platelet activating factor (PAF)-induced airway hyperresponsiveness in guinea pigs. Inhalation of PAF (1 microgram/ml) caused significant airway hyperresponsiveness to acetylcholine (p < 0.01) or histamine (p < 0.05). Pretreatment with tazanolast (30-300 mg/kg) produced a dose-dependent inhibition of airway hyperresponsiveness induced by PAF inhalation, and significant inhibition (p < 0.05) was obtained with the drug (300 mg/kg). Aspirin also inhibited PAF-induced airway hyperresponsiveness, while tranilast produced hardly any inhibition. From these results, it is suggested that tazanolast is effective in inhibiting airway hyperresponsiveness.

UI MeSH Term Description Entries
D008297 Male Males
D010972 Platelet Activating Factor A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. AGEPC,Acetyl Glyceryl Ether Phosphorylcholine,PAF-Acether,Phosphorylcholine, Acetyl Glyceryl Ether,1-Alkyl-2-acetyl-sn-glycerophosphocholine,Platelet Aggregating Factor,Platelet Aggregation Enhancing Factor,Platelet-Activating Substance,Thrombocyte Aggregating Activity,1 Alkyl 2 acetyl sn glycerophosphocholine,Aggregating Factor, Platelet,Factor, Platelet Activating,PAF Acether,Platelet Activating Substance
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006633 Histamine Antagonists Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. Antihistamine,Antihistamines,Histamine Antagonist,Antagonist, Histamine,Antagonists, Histamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic
D013777 Tetrazoles
D016535 Bronchial Hyperreactivity Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory. Bronchial Hyperreactivities,Hyperreactivities, Bronchial,Hyperreactivity, Bronchial
D062367 ortho-Aminobenzoates Benzoic acids, salts, or esters that contain an amino group attached to carbon number 2 or 6 of the benzene ring structure. 2-Aminobenzoates,6-Aminobenzoates,Anthranilates,Anthranilic Acids,o-Aminobenzoates,o-Aminobenzoic Acids,ortho-Aminobenzoic Acids,6 Aminobenzoates,Acids, Anthranilic,Acids, o-Aminobenzoic,Acids, ortho-Aminobenzoic,o Aminobenzoates,o Aminobenzoic Acids,ortho Aminobenzoates,ortho Aminobenzoic Acids

Related Publications

T Hashimoto, and Y Toyoda, and H Matsukawa, and Y Tsuriya, and Y Yanagihara
May 1998, American journal of respiratory and critical care medicine,
T Hashimoto, and Y Toyoda, and H Matsukawa, and Y Tsuriya, and Y Yanagihara
February 1997, Naunyn-Schmiedeberg's archives of pharmacology,
T Hashimoto, and Y Toyoda, and H Matsukawa, and Y Tsuriya, and Y Yanagihara
October 1992, The American review of respiratory disease,
T Hashimoto, and Y Toyoda, and H Matsukawa, and Y Tsuriya, and Y Yanagihara
June 2000, American journal of respiratory and critical care medicine,
T Hashimoto, and Y Toyoda, and H Matsukawa, and Y Tsuriya, and Y Yanagihara
March 1996, Journal of lipid mediators and cell signalling,
T Hashimoto, and Y Toyoda, and H Matsukawa, and Y Tsuriya, and Y Yanagihara
June 1995, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases,
T Hashimoto, and Y Toyoda, and H Matsukawa, and Y Tsuriya, and Y Yanagihara
November 1995, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
T Hashimoto, and Y Toyoda, and H Matsukawa, and Y Tsuriya, and Y Yanagihara
November 1989, Arerugi = [Allergy],
T Hashimoto, and Y Toyoda, and H Matsukawa, and Y Tsuriya, and Y Yanagihara
August 1994, Journal of toxicology and environmental health,
T Hashimoto, and Y Toyoda, and H Matsukawa, and Y Tsuriya, and Y Yanagihara
March 1993, Nihon Kyobu Shikkan Gakkai zasshi,
Copied contents to your clipboard!